1. Home
  2. News
  3. Acrux Limited
  4. Acrux receives $2.88m R&D Tax Incentive Rebate for FY23
More Acrux Limited news
Acrux LimitedASX: ACR

Acrux receives $2.88m R&D Tax Incentive Rebate for FY23

Nov 7, 2023 at 10:31 PM EST · Issued by Acrux Limited

Filed with ASX · Nov 7, 2023 at 10:31 PM EST · 1 page · English

On 6ix: 6ix.com/news/acrux-receives-dollar2.88m-randd-tax-incentive-rebate-for-fy23

Acrux Limited on 6ix

Story so far

  • Remaining balance of R&D Tax Incentive Rebate receivedOct 3, 2022

Earlier from Acrux

  • Investor Presentation - Acrux FY23 ResultsAug 24, 2023
  • Appendix 4E and FY23 Annual ReportAug 24, 2023
  • Activities Statement and Appendix 4CJul 26, 2023
  • Acruxs seventh generic dossier accepted by FDA for reviewJul 3, 2023
  • 4th FDA ANDA approval received - Dapsone Gel, 5%Jun 7, 2023

Later from Acrux

  • Address of Chair and CEO to AGMNov 28, 2023
  • Appendix 4C and Activities StatementJan 30, 2024
  • Appendix 4D and Half Year AccountsFeb 27, 2024
  • Investor Presentation Half Year AccountsFeb 27, 2024
  • Launch of Dapsone 5%, Gel in the United StatesApr 2, 2024
All Acrux news releases↗

Follow Acrux into a list and get an email when it puts out news.

Follow Acrux
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer